Publications by authors named "Samuel Goldlust"

Claim this Profile
R
Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System.
Afsaneh Shirani, Samuel A Goldlust, Olaf Stuve

Ther Adv Neurol Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Immune Check Point Blockade in -Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial.
Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, Andrew E Sloan, Tony J C Wang, Samuel A Goldlust

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
En Bloc Spondylectomy versus Separation Surgery for Spinal Metastases: A Systematic Review and Meta-Analysis.
Ahmad K AlMekkawi, Ashlesha Bhojane, Brandon Edelbach, James P Caruso, Salah G Aoun, Samuel A Goldlust

World Neurosurg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma.
Simon Khagi, Rupesh Kotecha, Na Tosha N Gatson, Suriya Jeyapalan, Huda Ismail Abdullah, Samuel A Goldlust

Oncologist· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative anemia is associated with prolonged hospital stay and increased facility discharges after glioblastoma resection.
Ahmad K Almekkawi, Ammar Adenwalla, James P Caruso, William H Hicks, Benjamin Rail, Samuel A Goldlust

Front Surg· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastoma.
Samuel A Goldlust, Samuel Singer, Lori A Cappello, Ahmad K AlMekkawi, Kangmin D Lee

Neurooncol Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma.
Samuel A Goldlust, Louis B Nabors, Sigmund Hsu, Nimish Mohile, Paul J Duic

Neurooncol Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, Samuel A Goldlust

Am J Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
Prashasti Agrawal, Kevin A David, Zhengming Chen, Suchitra Sundaram, Seo-Hyun Kim, Samuel A Goldlust

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian L Campian, John E Trusheim, Samuel A Goldlust

JAMA Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Treating Fields (TTFields) therapy vs physicians' choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19).
Jay-Jiguang Zhu, Samuel A Goldlust, Lawrence R Kleinberg, Jérôme Honnorat, Nancy Ann Oberheim Bush

Discov Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomas.
Deanna M Tiek, Beril Erdogdu, Roham Razaghi, Lu Jin, Norah Sadowski, Samuel A Goldlust

Sci Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial.
Samuel A Goldlust, Mojgan Kavoosi, Jennifer Nezzer, Mehran Kavoosi, Walter Korz

Toxins (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allele-specific DNA methylation is increased in cancers and its dense mapping in normal plus neoplastic cells increases the yield of disease-associated regulatory SNPs.
Catherine Do, Emmanuel L P Dumont, Martha Salas, Angelica Castano, Huthayfa Mujahed, Samuel Goldlust

Genome Biol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma.
Jiayi Huang, Rekha Chaudhary, Adam L Cohen, Karen Fink, Samuel Goldlust

J Neurooncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim, Samuel A Goldlust

J Transl Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim, Samuel A Goldlust

J Transl Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma.
Jay-Jiguang Zhu, Petya Demireva, Andrew A Kanner, Susan Pannullo, Maximilian Mehdorn, Samuel Goldlust

J Neurooncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply.
Michael Weller, Nicholas Butowski, David D Tran, Lawrence D Recht, Michael Lim, Samuel A Goldlust

Lancet Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Michael Weller, Nicholas Butowski, David D Tran, Lawrence D Recht, Michael Lim, Samuel A Goldlust

Lancet Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors.
Samuel A Goldlust, Robert Cavaliere, Herbert B Newton, Meier Hsu, Lisa M Deangelis

J Neurooncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Headache in patients with cancer.
Samuel A Goldlust, Jerome J Graber, Dana F Bossert, Edward K Avila

Curr Pain Headache Rep· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.
Herbert B Newton, Jennifer Dalton, Samuel Goldlust, Dennis Pearl

J Neurooncol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients.
Herbert B Newton, Samuel A Goldlust, Dennis Pearl

J Neurooncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor antagonists: novel therapy for the treatment of high-grade gliomas.
Narendra Nathoo, Samuel Goldlust, Michael A Vogelbaum

Neurosurgery· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis